Gao Mingming, Zhao Dong, Schouteden Sarah, Sorci-Thomas Mary G, Van Veldhoven Paul P, Eggermont Kristel, Liu George, Verfaillie Catherine M, Feng Yingmei
From the Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing, China (M.G., G.L.); Beijing Key Laboratory of Diabetes Research and Care, LuHe Hospital, Capital University, Peking, China (D.Z.); Interdepartmental Stem Cell Institute (S.S., K.E., C.M.V., Y.F.) and Laboratory of Lipid Biochemistry and Protein Interactions, Department of Cellular and Molecular Medicine (P.P.V.V.), Katholieke Universiteit Leuven, Leuven, Belgium; and Section on Molecular Medicine, Department of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC (M.G.S.-T.).
Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1900-9. doi: 10.1161/ATVBAHA.114.304006. Epub 2014 Jun 26.
Recently, we demonstrated that scavenger receptor type BI (SR-BI), a high-density lipoprotein (HDL) receptor, was expressed on murine hematopoietic stem/progenitor cells (HSPC) and infusion of reconstituted HDL and purified human apolipoprotein A-I (apoA-I) suppressed HSPC proliferation. We hypothesized that SR-B1 expression is required for the observed antiproliferative effects of HDL on HSPC.
SR-BI-deficient (SR-BI(-/-)) mice and wild-type controls were fed on chow or high-fat diet (HFD) for 8 to 10 weeks. Under chow diet, a significant increase in Lin(-) Sca1(+) cKit(+) cells (LSK cells, so-called HSPC) was found in the bone marrow of SR-BI(-/-) mice when compared with wild-type mice. HFD induced a further expansion of CD150(+)CD48(-) LSK cells (HSC), HSPC, and granulocyte monocyte progenitors in SR-BI(-/-) mice. Injection of reactive oxygen species inhibitor N-acetylcysteine attenuated HFD-induced HSPC expansion, leukocytosis, and atherosclerosis in SR-BI(-/-) mice. ApoA-I infusion inhibited HSPC cell proliferation, Akt phosphorylation and reactive oxygen species production in HSPC and plaque progression in low-density lipoprotein receptor knockout (LDLr(-/-)) apoA-I(-/-) mice on HFD but had no effect on SR-BI(-/-) mice on HFD. Transplantation of SR-BI(-/-) bone marrow cells into irradiated LDLr(-/-) recipients resulted in enhanced white blood cells reconstitution, inflammatory cell production, and plaque development. In patients with coronary heart disease, HDL levels were negatively correlated with white blood cells count and HSPC frequency in the peripheral blood. By flow cytometry, SR-BI expression was detected on human HSPC.
SR-BI plays a critical role in the HDL-mediated regulation HSPC proliferation and differentiation, which is associated with atherosclerosis progression.
最近,我们证明了清道夫受体BI型(SR-BI),一种高密度脂蛋白(HDL)受体,在小鼠造血干/祖细胞(HSPC)上表达,输注重组HDL和纯化的人载脂蛋白A-I(apoA-I)可抑制HSPC增殖。我们推测SR-B1表达是HDL对HSPC观察到的抗增殖作用所必需的。
将SR-BI缺陷(SR-BI(-/-))小鼠和野生型对照喂养8至10周的普通饲料或高脂饮食(HFD)。在普通饮食条件下,与野生型小鼠相比,SR-BI(-/-)小鼠骨髓中Lin(-) Sca1(+) cKit(+)细胞(LSK细胞,即所谓的HSPC)显著增加。HFD诱导SR-BI(-/-)小鼠中CD150(+)CD48(-) LSK细胞(HSC)、HSPC和粒细胞单核细胞祖细胞进一步扩增。注射活性氧抑制剂N-乙酰半胱氨酸可减轻HFD诱导的SR-BI(-/-)小鼠的HSPC扩增、白细胞增多和动脉粥样硬化。apoA-I输注可抑制HSPC细胞增殖、Akt磷酸化以及HSPC中活性氧的产生,并抑制HFD喂养的低密度脂蛋白受体敲除(LDLr(-/-))apoA-I(-/-)小鼠的斑块进展,但对HFD喂养的SR-BI(-/-)小鼠没有影响。将SR-BI(-/-)骨髓细胞移植到受辐射的LDLr(-/-)受体中导致白细胞重建增强、炎症细胞产生和斑块发展。在冠心病患者中,HDL水平与外周血白细胞计数和HSPC频率呈负相关。通过流式细胞术,在人HSPC上检测到SR-BI表达。
SR-BI在HDL介导的调节HSPC增殖和分化中起关键作用,这与动脉粥样硬化进展相关。